Wave Life Sciences (WVE) Liabilities and Shareholders Equity: 2015-2025
Historic Liabilities and Shareholders Equity for Wave Life Sciences (WVE) over the last 10 years, with Sep 2025 value amounting to $241.4 million.
- Wave Life Sciences' Liabilities and Shareholders Equity fell 32.67% to $241.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 5.27%. This contributed to the annual value of $352.2 million for FY2024, which is 28.10% up from last year.
- Latest data reveals that Wave Life Sciences reported Liabilities and Shareholders Equity of $241.4 million as of Q3 2025, which was down 4.35% from $252.4 million recorded in Q2 2025.
- Over the past 5 years, Wave Life Sciences' Liabilities and Shareholders Equity peaked at $358.5 million during Q3 2024, and registered a low of $146.4 million during Q4 2022.
- In the last 3 years, Wave Life Sciences' Liabilities and Shareholders Equity had a median value of $252.4 million in 2025 and averaged $264.5 million.
- Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first slumped by 35.33% in 2021, then soared by 87.82% in 2023.
- Quarterly analysis of 5 years shows Wave Life Sciences' Liabilities and Shareholders Equity stood at $207.0 million in 2021, then fell by 29.28% to $146.4 million in 2022, then soared by 87.82% to $274.9 million in 2023, then rose by 28.10% to $352.2 million in 2024, then crashed by 32.67% to $241.4 million in 2025.
- Its last three reported values are $241.4 million in Q3 2025, $252.4 million for Q2 2025, and $288.3 million during Q1 2025.